Home › Occupations › Microbiologists › Cambridge, MA
Microbiologists in Cambridge, MA: H-1B salaries
25 labor condition applications for this occupation with a work site in Cambridge, MA. Median offered base salary $100,002; middle half $75,000–$118,914.
By wage level
| Wage level | Median salary |
|---|---|
| Level I (entry) | $78,290 |
| Level II (qualified) | $107,125 |
| Level III (experienced) | $75,000 |
| Level IV (fully competent) | $138,900 |
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Employers
| Employer | LCAs | Median salary |
|---|---|---|
| Massachusetts Institute of Technology | 11 | $73,861 |
| ModernaTX, Inc. | 4 | $111,790 |
| Intergalactic Therapeutics Inc. | 1 | $110,000 |
| Wild Microbes Company, Inc. | 1 | $137,500 |
| Moderna, Inc. | 1 | $77,625 |
| LifeMine Therapeutics, Inc. | 1 | $104,250 |
| Intellia Therapeutics | 1 | $140,200 |
| Ginkgo Bioworks, Inc. | 1 | $138,900 |
| AbbVie Bioresearch Center Inc. | 1 | $168,000 |
| City Therapeutics, Inc. | 1 | $115,000 |
| Vedanta Biosciences, Inc | 1 | $86,528 |
| Biogen Inc. | 1 | $118,914 |
Job titles
- Research Scientist8
- Postdoctoral Associate2
- Research Associate1
- Scientist 11
- Senior Scientist1
- Research Associate, Therapeutic Area Research1
- Principal Research Associate, Oncology1
- Sr. Research Associate, Delivery Science1
- Scientist II, Fungal Microbiologist1
- Scientist1
- Sr. Scientist, ID Immunology1
- Senior Research Associate, Bioanalytics1
- Senior Organism Engineer 21
- Principal Research Scientist1
- Principal Research Associate1
H-1B sponsors in Cambridge, MA →
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).